Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9616822rdf:typepubmed:Citationlld:pubmed
pubmed-article:9616822lifeskim:mentionsumls-concept:C0001554lld:lifeskim
pubmed-article:9616822lifeskim:mentionsumls-concept:C0028128lld:lifeskim
pubmed-article:9616822lifeskim:mentionsumls-concept:C0004048lld:lifeskim
pubmed-article:9616822lifeskim:mentionsumls-concept:C0205082lld:lifeskim
pubmed-article:9616822lifeskim:mentionsumls-concept:C1273870lld:lifeskim
pubmed-article:9616822pubmed:issue4lld:pubmed
pubmed-article:9616822pubmed:dateCreated1998-8-4lld:pubmed
pubmed-article:9616822pubmed:abstractTextTreatment of amiodarone-induced pulmonary toxicity generally consists in simply discontinuing the drug with subsequent improvement in clinical condition and radiologic abnormalities. Corticosteroid therapy, when used, may accelerate recovery. Early diagnosis is however necessary and mandates the immediate cessation of the drug otherwise diffuse interstitial and alveolar damage can develop and lead to acute respiratory distress syndrome with a high rate mortality. To our knowledge, the use of inhaled nitric oxide to improve arterial oxygenation in amiodarone-induced ARDS has not yet been described. Here we report the case of a patient in whom 2 ppm inhaled nitric oxide in association with mechanical ventilation dramatically improved a life-threatening hypoxemia. We therefore submit that inhaled nitric oxide could be of benefit in patients with amiodarone-induced ARDS.lld:pubmed
pubmed-article:9616822pubmed:languagefrelld:pubmed
pubmed-article:9616822pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9616822pubmed:citationSubsetIMlld:pubmed
pubmed-article:9616822pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9616822pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9616822pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9616822pubmed:statusMEDLINElld:pubmed
pubmed-article:9616822pubmed:issn0761-8417lld:pubmed
pubmed-article:9616822pubmed:authorpubmed-author:JardinFFlld:pubmed
pubmed-article:9616822pubmed:authorpubmed-author:FellahiJ LJLlld:pubmed
pubmed-article:9616822pubmed:authorpubmed-author:ChironiGGlld:pubmed
pubmed-article:9616822pubmed:authorpubmed-author:QanadliS DSDlld:pubmed
pubmed-article:9616822pubmed:authorpubmed-author:TexereauJJlld:pubmed
pubmed-article:9616822pubmed:issnTypePrintlld:pubmed
pubmed-article:9616822pubmed:volume53lld:pubmed
pubmed-article:9616822pubmed:ownerNLMlld:pubmed
pubmed-article:9616822pubmed:authorsCompleteYlld:pubmed
pubmed-article:9616822pubmed:pagination210-2lld:pubmed
pubmed-article:9616822pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9616822pubmed:meshHeadingpubmed-meshheading:9616822-...lld:pubmed
pubmed-article:9616822pubmed:meshHeadingpubmed-meshheading:9616822-...lld:pubmed
pubmed-article:9616822pubmed:meshHeadingpubmed-meshheading:9616822-...lld:pubmed
pubmed-article:9616822pubmed:meshHeadingpubmed-meshheading:9616822-...lld:pubmed
pubmed-article:9616822pubmed:meshHeadingpubmed-meshheading:9616822-...lld:pubmed
pubmed-article:9616822pubmed:meshHeadingpubmed-meshheading:9616822-...lld:pubmed
pubmed-article:9616822pubmed:meshHeadingpubmed-meshheading:9616822-...lld:pubmed
pubmed-article:9616822pubmed:meshHeadingpubmed-meshheading:9616822-...lld:pubmed
pubmed-article:9616822pubmed:year1997lld:pubmed
pubmed-article:9616822pubmed:articleTitle[Management of severe amiodarone-induced pneumopathy using inhaled nitric oxide].lld:pubmed
pubmed-article:9616822pubmed:affiliationService de Réanimation Médicale, Hôpital Ambroise Paré, Boulogne.lld:pubmed
pubmed-article:9616822pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9616822pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:9616822pubmed:publicationTypeCase Reportslld:pubmed